EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?

Mattia Anfosso iD, Maria Schubert iD, Jann-Frederik Cremers iD, Sabine Kliesch iD, Michael Zitzmann iD, Simone Bier iD

Andrology · 2026-09 · 14 (6) · 1859-1872

DOI: 10.1111/andr.70292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, online erschienen am 25.06.2026. Verfasst von Mattia Anfosso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Andrology, Centre of Reproductive Medicine and Andrology (CeRA), University Hospital of Münster, Münster, Germany. Hauptthemen laut MEDLINE: Azoospermia, Sperm Retrieval, Hypogonadism, Testosterone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Research, Technology, and Space (BMFTR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility. Hypogonadism is common in NOA patients, and normal testosterone (T) levels are considered essential for spermatogenesis. Fertility‐preserving hormonal therapy (FpHT) has been proposed to optimize hormonal milieu and improve sperm retrieval rates (SRR) at microdissection testicular sperm extraction (mTESE), although evidence remains controversial and meta‐analyses have not shown consistent benefit.

Aims

To determine whether FpHT improves SRR in hypogonadal men with NOA undergoing mTESE.

Methods

We retrospectively evaluated 1256 selected men with NOA (601 Klinefelter syndrome [KS], 655 normal karyotype) from a cohort of 3086 men who underwent mTESE at our tertiary andrology center between 2010 and 2024. Patients with obstructive azoospermia, prior gonadotoxic exposure, or hypogonadotropic hypogonadism were excluded. All participants underwent comprehensive clinical, hormonal, and genetic assessment. Comparisons were performed between eugonadal and hypogonadal patients, and within the hypogonadal group, between those who received FpHT and those who did not.

Results

Hypogonadism was present in 49.9% of patients, predominantly in KS ( p < 0.001). FpHT significantly increased serum T levels in both groups (ΔT +3.1 nmol/L in KS; +5.6 nmol/L in 46, XY; p < 0.001). However, despite biochemical normalization, FpHT did not improve SRR in either karyotypic group (overall SRR: 32.4%). Multivariate analysis identified younger age as the sole independent predictor of successful retrieval in KS ( p = 0.011).

Conclusion

FpHT restores serum androgen levels but does not improve spermatogenic activity or sperm retrieval rates in men with NOA. These findings support current EAU guidelines and indicate that FpHT should be used to treat symptomatic hypogonadism rather than to enhance fertility outcomes before mTESE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzoospermiaSperm RetrievalHypogonadismTestosteroneHumansMaleRetrospective StudiesAdultMicrodissectionTreatment OutcomeKlinefelter SyndromeSpermatogenesisTestis

Stichwörter der Autor:innen

hormonal therapyhypogonadismmicrodissection testicular sperm extraction (mTESE)non-obstructive azoospermiasperm retrieval rate

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Andrology, Centre of Reproductive Medicine and Andrology (CeRA), University Hospital of Münster, Münster, Germany.

ORCID-Profile: Mattia Anfosso, Maria Schubert, Jann-Frederik Cremers, Sabine Kliesch, Michael Zitzmann, Simone Bier

Förderung

  • German Federal Ministry of Research, Technology, and Space (BMFTR)

Zitieren

APA

Anfosso, M., Schubert, M., Cremers, J. F., Kliesch, S., Zitzmann, M., & Bier, S. (2026). Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?. Andrology, 14(6), 1859-1872. https://doi.org/10.1111/andr.70292

Vancouver

Anfosso M, Schubert M, Cremers JF, Kliesch S, Zitzmann M, Bier S. Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?. Andrology. 2026;14(6):1859-1872. doi:10.1111/andr.70292

BibTeX
@article{Anfosso2026,
  author = {Anfosso, Mattia and Schubert, Maria and Cremers, Jann-Frederik and Kliesch, Sabine and Zitzmann, Michael and Bier, Simone},
  title = {Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?},
  journal = {Andrology},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {1859--1872},
  doi = {10.1111/andr.70292}
}
Kostenlos starten →